 PRINCETON, N.J. DEERFIELD, Ill.--BUSINESS WIRE--Otsuka Pharmaceutical Development Commercialization, Inc., and H. Lundbeck AS Lundbeck today announce that new Phase 3 data for brexpiprazole will be presented at the 2022 Alzheimers Association International Conference AAIC, which is being held virtually and in San Diego from July 31 through August 4. The oral presentation will be featured in the Neuropsychiatry and Behavioral Neurology: Agitation and Psychosis session on Thursday 